2,6-BIS((S)-4-METHYL-4,5-DIHYDROOXAZOL-2-YL)PYRIDINE, 95%, 25g

6-(3-methoxyphenyl)-6-oxohexanoic acid, 97.0%, 1g

6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 97%, 500mg

2-Bromo-N-(4-chlorophenyl)aniline, 98%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopentylpropanoic acid, 95.0%, 5g

(S)-4-N-Boc-Piperazine-2-carboxylic acid, 97.0%, 25g

Cinnamaldehído, mínimo 98 %, para síntesis, 250 ml, envase de vidrio

(7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHANOL, 95.0%, 100mg

10-Undecenoic Acid>98.0%(GC)(T)25g

tert-butyl 4-[(2-amino-1,3-thiazol-4-yl)methyl]piperazine-1-carboxylate, 95.0%, 500mg

tert-Butyl N-(4-fluoro-3-nitrophenyl)carbamate, 98%, 250mg

6-Iodo-3,4-dihydro-2H-pyrano[3,2-b]pyridine, 95%, 1g

2-Chloromethyl-6-trifluoromethyl-nicotinic acid ethyl ester, 95.0%, 500mg